Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)
An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.
Price
Last close 39.68 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.
What it costs
| Expense ratio | 6.27% |
| Assets under management | 2.8M USD |
| Net asset value per share | 37.80 USD |
| Inception | Oct 1, 2025 |
| Sponsor | Direxion |
| Asset class | Equity |
| Holdings the fund reports | 0 |
Market data, supplied Oct 15, 2026.
What it holds
The largest 11 by weight of the 11 holdings in the snapshot of Oct 15, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.
| # | Holding | Weight |
|---|---|---|
| 1 | BIOEW5 SWAP ASSET LEG (BIOEW5BCL) (not a company) | 51.86% |
| 2 | BIOEW5 SWAP ASSET LEG (BIOEW5MLL) (not a company) | 51.03% |
| 3 | BIOEW5 SWAP ASSET LEG (BIOEW5CTL) (not a company) | 39.14% |
| 4 | DREYFUS GOVT CASH MAN INS (a fund) | 34.02% |
| 5 | AMGEN INC | 13.09% |
| 6 | GILEAD SCIENCES INC | 12.31% |
| 7 | GOLDMAN FINL SQ TRSRY INST 506 | 11.76% |
| 8 | REGENERON PHARMACEUTICALS | 11.56% |
| 9 | VERTEX PHARMACEUTICALS INC | 11.28% |
| 10 | ARGENX SE - ADR | 9.73% |
| 11 | GOLDMAN SACHS FIN GOV 465 INSTITUT | 6.68% |
Market data, supplied Oct 15, 2026.
Sector weights
n/a. Not supplied for this fund.
Country weights
| Other | 77.39% |
| United States | 18.85% |
| Netherlands | 3.76% |
Market data, supplied Oct 15, 2026.
Look-through value
Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.